<SEC-DOCUMENT>0001193125-17-307180.txt : 20171010
<SEC-HEADER>0001193125-17-307180.hdr.sgml : 20171010
<ACCEPTANCE-DATETIME>20171010170033
ACCESSION NUMBER:		0001193125-17-307180
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171010
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171010
DATE AS OF CHANGE:		20171010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COOPER COMPANIES INC
		CENTRAL INDEX KEY:			0000711404
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				942657368
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08597
		FILM NUMBER:		171131040

	BUSINESS ADDRESS:	
		STREET 1:		6140 STONERIDGE MALL RD
		STREET 2:		STE 590
		CITY:			PLEASANTON
		STATE:			CA
		ZIP:			94588
		BUSINESS PHONE:		9254603600

	MAIL ADDRESS:	
		STREET 1:		6140 STONERIDGE MALL ROAD
		STREET 2:		SUITE 590
		CITY:			PLEASANTON
		STATE:			CA
		ZIP:			94588

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COOPERVISION INC
		DATE OF NAME CHANGE:	19870701
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d472219d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): October&nbsp;10, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>THE COOPER COMPANIES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-8597</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">94-2657368</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(925) <FONT STYLE="white-space:nowrap">460-3600</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c)</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of
the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). Emerging growth company&nbsp;&nbsp;&#9744; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;10, 2017, The Cooper Companies, Inc. issued a press release that provides
update on manufacturing facilities in Puerto Rico. A copy of the press release is filed as Exhibit 99.1 to this Current Report and incorporated by reference herein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit<BR>No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d472219dex991.htm">Press Release, dated October&nbsp;10, 2017, of The Cooper Companies, Inc. </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE COOPER COMPANIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Albert G. White, III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Albert G. White, III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President, Chief Financial</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Officer and Chief Strategy Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: October&nbsp;10, 2017 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d472219dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g472219g04z28.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g472219g86r85.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NEWS RELEASE</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONTACT:</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kim Duncan</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vice President, Investor Relations</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Cooper Companies, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>ir@cooperco.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">6140 Stoneridge Mall Road</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Suite 590</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Pleasanton, CA 94588</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">925-460-3663</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>www.coopercos.com</U></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE COOPER COMPANIES PROVIDES UPDATE ON </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MANUFACTURING FACILITIES IN PUERTO RICO </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PLEASANTON, Calif., October</B><B></B><B>&nbsp;10, 2017</B> &#150; The Cooper Companies, Inc. (NYSE: COO) today announced that following a comprehensive
onsite assessment of its CooperVision manufacturing facility in Juana Diaz, Puerto Rico, following the impact of Hurricane Maria, the facility sustained relatively minor damage. Manufacturing operations have been restored to approximately 90% and
are expected to continue ramping up over the coming weeks with the support of the local power grid and generators. Packaging and labeling operations have also been restored and product is being shipped out of Puerto Rico. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While CooperVision works to restore full operational capacity, it continues to support its employees, their families, and suppliers affected by Hurricane
Maria. CooperVision employs approximately 1,500 people in Puerto Rico and their safety and well-being remains our priority. Unfortunately some of our employees suffered significant losses to their homes and property, yet despite their personal
struggles the majority of employees have returned to work. We are humbled by the resiliency of our Puerto Rico colleagues and their commitment to restore our operations. In light of these events, Cooper has formed the Puerto Rico Relief Fund to
directly support employees who have suffered catastrophic losses along with supporting the most critical emergency needs in the surrounding communities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cooper plans to provide financial information with regard to the impact of Hurricane Maria when it reports fourth quarter and full year 2017 earnings on
December&nbsp;7, 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About The Cooper Companies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Cooper Companies, Inc. (&#147;Cooper&#148;) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A
Quality of Life Company&#153; with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a
wide range of high-quality products for contact lens wearers and providing focused practitioner support. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women&#146;s health, fertility and diagnostics. Headquartered
in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit <U>www.coopercos.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; as defined by the Private Securities Litigation Reform Act of 1995.&nbsp;Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements which
are other than statements of historical fact, including our 2017 Guidance and all statements regarding acquisitions including the acquired companies&#146; financial position, market position, product development and business strategy, expected cost
synergies, expected timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities&#146; future expenses, sales and diluted earnings per share are forward looking. In
addition, all statements regarding anticipated growth in our revenue, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are
forward-looking.&nbsp;To identify these statements look for words like &#147;believes,&#148; &#147;expects,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148; &#147;seeks,&#148; &#147;intends,&#148; &#147;plans,&#148;
&#147;estimates&#148; or &#147;anticipates&#148; and similar words or phrases.&nbsp;Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: adverse
changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries that could adversely affect our global markets, and the potential adverse
economic impact and related uncertainty caused by these items, including but not limited to, the United Kingdom&#146;s election to withdraw from the European Union; foreign currency exchange rate and interest rate fluctuations including the risk of
fluctuations in the value of foreign currencies or interest rates that would decrease our revenues and/or earnings; our indebtedness and associated interest expense could adversely affect our financial health, prevent us from fulfilling our debt
obligations or limit our ability to borrow additional funds; changes in tax laws or their interpretation and changes in statutory tax rates, including but not limited to, United States and other countries with proposed changes to tax laws, some of
which may affect our taxation of earnings recognized in foreign jurisdictions and/or negatively impact our effective tax rate; acquisition-related adverse effects including the failure to successfully obtain the anticipated revenues, margins and
earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory
approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or
refinancing of debt owed by us on a timely basis and on reasonable terms); a major disruption in the operations of our manufacturing, research and development or distribution facilities, due to technological problems, including any related to
integration of acquisitions, natural disasters, system upgrades or other causes; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to technological
problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades; disruptions in supplies of raw materials, including but not limited to, components used to manufacture our
silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care
industry including the contact lens industry and the medical device industry; compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of third party
information, including but not limited to product recalls, warning letters, and data security breaches; legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product
liability, patent infringement or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by
competitors, new products and patents attained by competitors, and competitors&#146; expansion through acquisitions; reduced sales, loss of customers and costs/expenses related to recalls; failure to receive, or delays in receiving, U.S. or foreign
regulatory approvals for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third party payors for our products and services; the requirement to provide for a significant liability or to write off, or
accelerate depreciation on, a significant asset, including goodwill, and idle manufacturing facilities and equipment; the success of our research and development activities and other <FONT STYLE="white-space:nowrap">start-up</FONT> projects;
dilution to earnings per share from acquisitions or issuing stock; changes in accounting principles or estimates; environmental risks; and other events described in our Securities and Exchange Commission filings, including the &#147;Business&#148;
and &#147;Risk Factors&#148; sections in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended October&nbsp;31, 2016, as such Risk Factors may be updated in quarterly filings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required
by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">COO-G</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: The Cooper Companies, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g472219g04z28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472219g04z28.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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%T5 '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g472219g86r85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472219g86r85.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M\C?$2W3PI\;;F>Q_=B.[AO$"C[K-M<\?4F@#/^+%_/J?Q3UQI-SF*?R$7T5
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MP_D?0CH1V(H O8H 9)+%$R+)(B&1MJ!B!N/7 ]3P: /E7XR?\EKF^MM_Z"M
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MJ2ZGI\*' BEAWQC_ '=P(Q]* )8?#OQ&^)^HQ27<=[<JO N+P&.&,=\< ?\
M?(S0!])?#_P)8^ ?#XL+9_/N93ON;@K@R-_11V'U]30!\T^,M/35?C?J&FRN
MT<=WJJP,ZC)4,P7(_.@#3O\ P)\2/ASJ,[:*;^2U)XN-.+,LB]BR#)'XC\:
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M ](LOVD/#<D0-[I&HV\F.5CV2#\R1_*@"U_PT7X/_P"?+5O^_,?_ ,70 ?\
M#1?@_P#Y\M6_[\Q__%T '_#1?@__ )\M6_[\Q_\ Q= !_P -%^#_ /GRU;_O
MS'_\70 ?\-%^#_\ GRU;_OS'_P#%T =%X,^+&@>.=9DTO2[>^CGCA,Q,\:JN
MT$#J&//S"@#P/7O^3AF_[#D7_HQ: /?[_P 2>)=8\07VD^$+6P$6FL([N_U
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M_P!/N$N+28;HY4Z,,XX_*@"U0 4 % !0!3U'2M.U>V-MJ5C;WD)_@GC#C]:
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MX1TYO$$"0ZH8SYR(H4#YCC(' .W!('?- &Y0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!0MM'L;/5K_5((=EY?B,7#[B=^P$+QG P">E %^@ H * "@ H
' * "@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
